Skip to main content

stock

BEAM · Beam Therapeutics Inc.

What Beam Therapeutics Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live BEAM price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BEAM.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
103,287,665 as of 2026-07-28 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-242.3%
Net
-55.4%

Returns

ROE
-8.1%
ROA
-6.2%

Health

Current ratio
14.6x
Debt/equity
0.1x

Deep value

NCAV
$859.68M
NCAV per share
$8.32
Price/NCAV
Locked
NNWC
-$99.09M
NNWC per share
-$0.96
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$490,000—Gross profit: unreported by this company.-$126.55M-$122.68M
10-Q filed 2026-08-04
2026-03-31$31.74M—Gross profit: unreported by this company.-$107.22M-$94.32M
10-Q filed 2026-08-04
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$114.11M—Gross profit: unreported by this company.-$17.45M$243.20M
DEF 14A filed 2026-04-17
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$9.70M—Gross profit: unreported by this company.-$126.81M-$112.73M
10-Q filed 2025-11-04
2025-06-30$8.47M—Gross profit: unreported by this company.-$120.15M-$102.14M
10-Q filed 2026-08-04
2025-03-31$7.47M—Gross profit: unreported by this company.-$119.29M-$108.33M
10-Q filed 2026-08-04
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$30.07M—Gross profit: unreported by this company.-$100.04M-$90.35M
DEF 14A filed 2026-04-17
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$14.27M—Gross profit: unreported by this company.-$106.50M-$96.67M
10-Q filed 2025-11-04
Assets
$1.39B
Equity
$1.07B

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$139.74M-$383.69M-$79.99M-$360.05M
2024-12-31$63.52M-$415.57M-$376.74M-$356.19M
2023-12-31$377.71M-$176.49M-$132.53M-$182.93M
2022-12-31$60.92M-$338.48M-$289.09M-$26.42M
2021-12-31$51.84M-$392.46M-$370.68M-$113.08M
2020-12-31$24,000-$132.76M-$194.59M-$112.10M
2019-12-31$18,000-$75.15M-$78.33M-$84.52M

Company filings

events

  • Results

    Results
    Aug 48-K
  • Shareholder vote results

    Shareholder vote results
    Jun 88-K
  • Results

    Results
    May 78-K
  • Agreement ended

    Agreement ended
    Mar 58-K
  • Material agreement, Results, New debt

    Material agreementResultsNew debt
    Feb 248-K
  • Material agreement

    Material agreement
    Feb 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Cavanagh Bethany J

    SVP, Finance and Treasurer

    Sale$4,565

    Oct 2, 4:05 PM ET

  • Simon Amy

    Chief Medical Officer

    Sale$429,037

    Jul 29, 4:05 PM ET

All insider trades for BEAM

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

All funds

News

Stories that named BEAM, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about BEAM.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about BEAM.

nakagai

Signals on BEAM come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BEAM board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Beam Therapeutics Inc. (BEAM): SEC filings, financials and insider trades · Nakagai